Retroperitoneal Lymph Node Dissection: Difference between revisions

No edit summary
Line 148: Line 148:
* '''Refers to the accumulation of chylomicron containing lymphatic fluid in the peritoneal cavity.'''
* '''Refers to the accumulation of chylomicron containing lymphatic fluid in the peritoneal cavity.'''
* Occurs in 0.2-2% of patients undergoing primary RPLND and 2-7% of patients undergoing PC-RPLND
* Occurs in 0.2-2% of patients undergoing primary RPLND and 2-7% of patients undergoing PC-RPLND
* '''Management options (5):'''
* '''<span style="color:#ff0000">Management options (5):</span>'''
*# '''Paracentesis'''
*# '''<span style="color:#ff0000">Paracentesis</span>'''
*# '''Low-fat/medium-chain triglyceride diet'''
*# '''<span style="color:#ff0000">Low-fat/medium-chain triglyceride diet</span>'''
*# '''Somatostatin/octreotide.'''
*# '''<span style="color:#ff0000">Somatostatin/octreotide.</span>'''
*# '''Indwelling drain'''
*# '''<span style="color:#ff0000">Indwelling drain</span>'''
*# '''Total parenteral nutrition'''
*# '''<span style="color:#ff0000">Total parenteral nutrition</span>'''


== Auxiliary procedures ==
== Auxiliary procedures ==